© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Furosemide belongs to the class of pharmaceuticals known as loop diuretics, with broad use in both human and veterinary medicine. Chemically, this substance carries the molecular formula C12H11ClN2O5S and a molecular weight of 330.74 g/mol. Produced as a synthetic compound, furosemide first gained FDA approval in the 1960s, transforming the treatment of conditions marked by edema and high blood pressure. With its solid track record in clinical settings, many clinicians trust furosemide not only for its effectiveness but also for its manageable safety profile when used as directed.
On a molecular level, furosemide contains a sulfonamide group, a carboxylic acid group, and a chlorine atom, arranged on a benzene ring that shapes its reactivity and biological effects. This arrangement makes furosemide a white to off-white crystalline powder at room temperature. The substance tends to clump under humidity, so laboratories and pharmacies often store it in air-tight containers, away from direct light and heat. Its density sits near 1.73 g/cm³, which means it feels denser and heavier than many other powders used in pharmaceutical manufacturing. The melting point usually falls in the range of 206 to 209°C, and it resists breaking down under mild thermal conditions.
In its most typical form, furosemide appears as a fine powder or crystalline solid. Raw material suppliers sometimes offer larger crystal forms or compacted flakes when bulk volume shipping calls for less dust and greater ease of handling. In compounding pharmacies, the powder dissolves in carefully measured volumes of solvents to create oral or injectable solutions. Solubility in water remains low—less than 1 mg/mL at 25°C—so technicians often use alkaline solutions to enhance the drug’s dissolution for intravenous dosing. People working with the solid powder wear gloves and masks because inhalation or contact with skin may cause irritation, even though it is not classified as volatile.
Furosemide’s trade and import rely on accurate classification, usually landing under HS Code 29350090 (sulfonamides). Manufacturers typically start with benzene derivatives and sulfonamide intermediates, running these through a series of controlled chemical reactions. Quality control protocols at almost every major pharmaceutical supplier require rigorous identity testing—including melting point, NMR spectroscopy, and TLC chromatographic profiling—before a batch earns approval for sale or compounding. The raw materials, often sourced from major chemical hubs in China and India, arrive packaged with documentation about trace impurities and test results.
Furosemide, while generally considered safe for professional handling, demonstrates moderate risk as a raw chemical. Direct exposure to eyes or mucous membranes may lead to irritation and inflammation. Inhalation of fine powder may cause discomfort in sensitive individuals, so personal protective equipment remains standard during blending, weighing, or dissolution. Accidental spills need cleanup with industrial vacuum systems or damp cloths to prevent airborne dust. The material does not present an acute environmental hazard in small spills, but persistent or careless disposal could potentially affect aquatic systems. Wastewater treatment plants break down pharmaceutical traces over time, but best practice always pushes for contained disposal and community education about unused drugs.
Pharmacies and manufacturers keep furosemide in tightly sealed, light-resistant containers at a temperature below 25°C. The material’s tendency to degrade under light and moisture makes warehouse protocols strict—shelving avoids sunlight, container seals stay checked, and stock rotates by production batch. Bulk shippers use drums or multi-layer bags, sometimes including silica gel packs or vacuum-seal barriers to preserve integrity over weeks in transit. In liquid form as a prepared solution, furosemide needs refrigeration and use within days to avoid breakdown of active compound. Properly labeled and classified shipments meet international standards for drug transportation, and licensing covers any cross-border trade under relevant customs regulations.
Though most people know furosemide as a medication, raw material suppliers also recognize demand from research labs, veterinary hospitals, and even chemical analysis companies. Some studies explore the compound as a model sulfonamide in environmental toxicology. Lab managers control exposure risk by relying on closed-system balances, and furosemide’s solid-state stability supports long-term storage for slow-moving projects. Clinics preparing custom doses for cardiac or renal patients appreciate the variety of concentrations possible by dissolving the raw powder in sterile mediums.
Workers in medicine and science can advocate for best practices in handling furosemide. That starts with education and extends to careful documentation—from COA checks at reception of raw materials to the secure tracking of compounded solutions or finished tablets. Hospital pharmacies maintain batch records, labeling standards, and temperature logs so that potency never slips by unnoticed during storage. Environmental protection arises from proper disposal—not just for expired solid material but also from discarding liquid solutions down off-limits drains. By working together, supply chain partners build public trust in furosemide’s safety, keep hazards in check, and help ensure that every dose meets the standards expected by patients and families.
